Outcomes of programmed death protein-1 inhibitors treatment of chronic active Epstein Barr virus infection: A single center retrospective analysis

Outcomes of programmed death protein-1 inhibitors treatment of chronic active Epstein Barr virus infection: A single center retrospective analysis

IntroductionChronic active Epstein-Barr virus (CAEBV) disease is a high-mortality disease, which is characterized by persistent infectious mononucleosis-like symptoms. There is no standard treatment for CAEBV and allogeneic hematopoietic stem cell transplantation (HSCT) was considered the only poten...

Full description

Bibliographic Details
Main Authors: Yaxian Ma, Peiling Zhang, Yuhan Bao, Hui Luo, Jiachen Wang, Liang Huang, Miao Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Immunology
Subjects:
Epstein-Barr virus
chronic active Epstein-Barr virus infection
programmed death protein-1 inhibitors
lymphoma
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1093719/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1093719/full

Similar Items